Proton therapy for prostate cancer: The initial Loma Linda University experience

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 2, 2004, Pages 348-352

  Slater, Jerry D ^a,b   Rossi, Carl J ^a   Yonemoto, Les T ^a   Bush, David A ^a   Jabola, B Rodney ^a   Levy, Richard P ^a   Grove, Roger I ^a   Preston, William ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Conformal radiotherapy; Prostate cancer; Proton beam therapy

Indexed keywords

BIOCHEMISTRY; DISEASE CONTROL; DOSIMETERS; PATIENT TREATMENT; TUMORS;

MORBIDITY; PROSTATE CANCER; PROTON RADIATION THERAPY;

PROTON IRRADIATION;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMICAL ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOTONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE;

EID: 2442455735     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.011     Document Type: Article

References (17)

1. Slater J.D., Yonemoto L.T., Rossi C.J. Jr, et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 42:1998;299-304
2. Archambeau J.O., Bennett G.W., Levine G.S., et al. Proton radiation therapy. Radiology. 110:1974;445-457
3. Slater J.D., Rossi C.J. Jr., Yonemoto L.T., et al. Conformal proton therapy for early-stage prostate cancer. Urology. 53:1999;978-984
4. Slater J.M., Archambeau J.O., Miller D.W., et al. The proton treatment center at Loma Linda University Medical Center Rationale for and description of its development. Int J Radiat Oncol Biol Phys. 22:1992;383-389
5. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1035-1041
6. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
7. Cox D. Regression models and life tables (with discussion). J R Stat Soc. B34:1972;187-220
8. Ryu J.K., Winter K., Michalski J.M., et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). Int J Radiat Oncol Biol Phys. 54:2002;1036-1046
9. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116
10. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am. 28:2001;555-565
11. Zagars G.K., Pollack A., von Eschenbach A.C. Prognostic factors for clinically localized prostate carcinoma: Analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. 79:1997;1370-1380
12. Pollack A., Zagars G.K., Antolak J.A., et al. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure Analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 54:2002;677-685
13. Hanlon A.L., Diratzouiann H., Hanks G.E. Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;297-303
14. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with 3-D conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500
15. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3-D conformal treatment 5 year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510
16. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 54:2002;1314-1321
17. Cella L., Lomax A., Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 49:2001;217-223